Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV-supported projects
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Product availability maps
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Tool Kits
Injectable Artesunate tool kit
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Socially responsible agreements
Our clinical centre partners
Our impact
Milestones
Real life stories
Better medicines for children
Gender equity
Global health security
Malaria and COVID-19
Tackling antimicrobial resistance
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
Five species
Parasite lifecycle
Malaria facts & figures
Malaria treatment
History of antimalarials
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
Malaria
Libre
About Malaria
Libre
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
Press releases
Press releases
Filter
All
R&D
Donors
General
Open source
Partner
Access & product management
All
R&D
Donors
General
Open source
Partner
Access & product management
23 found
This World Malaria Day MMV recognizes Swiss Malaria Group's commitment to defeating malaria
19 Apr 2021
Endemic countries in South America meet to discuss new tools for malaria elimination
02 Nov 2020
Global call to boost access to lifesaving malaria treatment for pregnant women in Africa
15 Oct 2020
This World Malaria Day MMV supports Swiss Malaria Group's call for urgent action
25 Apr 2020
MMV and LSTM collaborate to fill data gap on use of antimalarials during pregnancy
08 Mar 2020
Research for new drugs against neglected diseases and malaria in Brazil to receive funding boost totaling BRL 43.5 million
27 Nov 2019
Country leaders pledge to boost malaria innovation and access to new and existing antimalarials
11 Nov 2019
MMV and Novartis expand partnership
15 Jun 2016
Pyramax® Granules becomes first paediatric antimalarial to receive EMA Article 58 positive scientific opinion
20 Nov 2015
GHIT invests $10.7 million in malaria, TB, leishmaniasis and dengue research
05 Nov 2015
New compound has the potential to treat malaria patients in a single dose
17 Jun 2015
GHIT, Takeda and MMV progress first-in-class antimalarial DSM265 to patient trials in Peruvian Amazon
05 Jun 2015
Merck Serono and MMV sign agreement to develop potential antimalarial therapy
01 Apr 2015
Partnership reaches important milestone
14 Nov 2011
Antimalarial drug discovery urgently needs prioritised 5-year plan to avoid missing opportunities
11 Oct 2011
Molecule moves through preclinical development in record time
02 Sep 2011
Sanofi-aventis and MMV join forces to develop innovative malaria drugs
05 May 2011
Anacor Pharmaceuticals and MMV sign agreement to pursue promising compound for malaria
18 Mar 2011
Jomaa Pharma and MMV to co-develop novel malaria treatment based on fosmidomycin
15 Feb 2011
Single-dose cure for malaria edges closer to the clinic
08 Feb 2011
MMV and Anacor join hands in hunt for new antimalarial compounds
26 Apr 2010
MMV supports trials of a new preventive treatment option for pregnant women
23 Apr 2010
Pyramax® submitted to EMA for regulatory approval
08 Apr 2010